C the Signs
PrivateLast Round
Series B
Jan 29, 2025
Total Funding Raised
$16.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
C the Signs operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series B round in January 2025.
C the Signs is a healthcare technology company that provides an AI-powered clinical decision support platform to identify patients at risk of cancer at the earliest possible stage.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, EHR & EMR, Healthcare Analytics, Workflow Automation, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
C the Signs Comparables
Compare C the Signs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CancerIQ | 82% | |
| Oatmeal Health | 69% | |
| Optellum | 68% |
For institutional investors. Book with your work email.
C the Signs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 29, 2025 | ||||
| Accelerator | Feb 26, 2024 | ||||
| Series A | Feb 4, 2022 | ||||
| Grant | Oct 23, 2018 | ||||
| Grant | Jul 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
C the Signs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SBRI Healthcare | Grant |
| Khosla Ventures | Series B |
| Acequia Capital | Series A, Series B |
| Ataraxia | Series A, Series B |
| MMC Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 132, 338% of headcount.
- Jul 13, 2026
Open roles increased to 123, 315% of headcount.
For institutional investors. Book with your work email.
C the Signs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about C the Signs's valuation, stock price, and market status.
Is C the Signs a public or private company?
C the Signs is a private company.
What is the current stock price of C the Signs?
C the Signs is a private company, so its shares have no public market price. Caplight tracks C the Signs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is C the Signs worth (valuation)?
Valuation information for C the Signs is not publicly available.
Can I buy C the Signs stock?
C the Signs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was C the Signs's last funding round?
C the Signs's most recent funding round was Series B on January 29, 2025.
Who are the main investors in C the Signs?
Key investors in C the Signs include Khosla Ventures, MMC Ventures.
Will C the Signs IPO soon?
No public IPO plans have been announced for C the Signs.
How can I track C the Signs secondary market activity?
Caplight tracks bids, offers, and trades in C the Signs's shares on secondary markets.